NCT00040521已完成2 期
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Orally Administered Recombinant Human Interleukin-11 (rhIL-11) for the Treatment of Patients With Active Crohn's Disease
Wyeth is now a wholly owned subsidiary of Pfizer2 个研究点 分布在 1 个国家开始时间: 2002年4月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to assess the activity of multiple doses of oral rhIL-11 in patients with active Crohn's disease (Crohn's Disease Activity Index [CDAI] score from 220-400).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Documented, signed and dated informed consent to participate in this trial prior to any study related procedures being performed.
- •Men and women age 16 years and over.
- •Diagnosis of Crohn's disease for at least 6 months that has been appropriately documented and confirmed by radiological studies, endoscopy (with histological examination preferred), or surgical pathology (Patients with a diagnosis of Crohn's disease for less than 6 months may be included if the diagnosis is confirmed by a biopsy characteristic of Crohn's disease)
排除标准
- •Use of the following medications within the specified time period prior to randomization:
- •Nonsteroidal anti-inflammatory drugs (NSAIDs; including Cyclooxygenase-2 [COX-2] inhibitors and >500 mg/day acetylsalicylic acid)
- •Codeine-containing compounds
- •Corticosteroid enemas
研究者
研究点 (2)
Loading locations...
相似试验
终止
1 期
Study Evaluating rhIL-11 in Left-Sided Ulcerative ColitisUlcerative ColitisInflammatory Bowel DiseaseNCT00038922Wyeth is now a wholly owned subsidiary of Pfizer
已完成
4 期
Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALLPancytopenia Due to ChemotherapyNCT02314273Shanghai Children's Medical Center120
已完成
2 期
IL-11 in Women With Von Willebrand Disease and Refractory MenorrhagiaVon Willebrand DiseaseNCT00524342Margaret Ragni7
终止
2 期
IL-11 in Adults With Von Willebrand Disease Undergoing SurgeryVon Willebrand DiseaseNCT00524225Margaret Ragni3
撤回
不适用
Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune ThrombocytopeniaPurpura, Thrombocytopenic, IdiopathicNCT01317966Ming Hou